Gilead Sciences

Gilead Sciences is an American biopharmaceutical company that researches, develops and commercializes innovative drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.

History

File:Gilead Sciences logo.svg

Gilead Sciences logo

Founded in June 1987 by Michael L. Riordan, a medical doctor, Gilead Sciences has its headquarters in Foster City, California. The company name "Gilead" refers to the Balm of Gilead, a historic region known for its medicinal plants.

Research and Development

Gilead Sciences is known for its rapid drug development, particularly in the field of antiviral drugs. The company's research and development efforts are focused on the areas of HIV/AIDS, liver diseases, oncology, respiratory diseases, and cardiovascular conditions.

Products

Gilead's portfolio includes a number of groundbreaking drugs, such as Truvada, Atripla, Complera, Stribild, Descovy, and Genvoya for HIV; Viread for hepatitis B; and Sovaldi, Harvoni, Epclusa, and Vosevi for hepatitis C.

Controversies

Gilead has faced criticism and legal challenges for its high drug prices, particularly for its hepatitis C drugs Sovaldi and Harvoni. The company has also been involved in controversies related to its HIV drug Truvada.

See Also

• Biopharmaceutical
• Antiviral drug
• HIV
• Hepatitis B
• Hepatitis C
• Influenza

‎

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian